ReP USP - Resultado da busca

Artigo de periodico
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group (2024)
Panchawagh, Suhrud; Ravichandran, Naveen; Barman, Bhupen; Nune, Arvind; Javaid, Mahnoor; Gracia-Ramos, Abraham Edgar; Day, Jessica; Joshi, Mrudula; Kuwana, Masataka; Shinjo, Samuel Katsuyuki
Fonte: Rheumatology international. Unidade: FM
Assuntos: COVID-19, DIABETES MELLITUS, VACINAÇÃO, ESTUDOS TRANSVERSAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PANCHAWAGH, Suhrud et al. COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group. Rheumatology international, v. 44, n. 1, p. 73-80, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/58770. Acesso em: 27 jun. 2025.
APA
Panchawagh, S., Ravichandran, N., Barman, B., Nune, A., Javaid, M., Gracia-Ramos, A. E., et al. (2024). COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group. Rheumatology international, 44( 1), 73-80. doi:10.1007/s00296-023-05496-y
NLM
Panchawagh S, Ravichandran N, Barman B, Nune A, Javaid M, Gracia-Ramos AE, Day J, Joshi M, Kuwana M, Shinjo SK. COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group [Internet]. Rheumatology international. 2024 ; 44( 1): 73-80.[citado 2025 jun. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58770
Vancouver
Panchawagh S, Ravichandran N, Barman B, Nune A, Javaid M, Gracia-Ramos AE, Day J, Joshi M, Kuwana M, Shinjo SK. COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group [Internet]. Rheumatology international. 2024 ; 44( 1): 73-80.[citado 2025 jun. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58770
Artigo de periodico
Listening to patients, for the patients: the COVAD Study-Vision, organizational structure, and challenges (2024)
Joshi, Mrudula; Darooka, Naitica; Saha, Sreoshy; Dyball, Sarah; Sen, Parikshit; Yaadav, Praggya; Javaid, Mahnoor; Kadam, Esha; Shinjo, Samuel Katsuyuki ; Dey, Dzifa
Fonte: International journal of rheumatic diseases. Unidade: FM
Assuntos: REUMATOLOGIA, VOZ, COVID-19, QUESTIONÁRIOS, ÍNDIA, MÉXICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JOSHI, Mrudula et al. Listening to patients, for the patients: the COVAD Study-Vision, organizational structure, and challenges. International journal of rheumatic diseases, v. 27, n. 5, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/76828. Acesso em: 27 jun. 2025.
APA
Joshi, M., Darooka, N., Saha, S., Dyball, S., Sen, P., Yaadav, P., et al. (2024). Listening to patients, for the patients: the COVAD Study-Vision, organizational structure, and challenges. International journal of rheumatic diseases, 27( 5). doi:10.1111/1756-185X.15161
NLM
Joshi M, Darooka N, Saha S, Dyball S, Sen P, Yaadav P, Javaid M, Kadam E, Shinjo SK, Dey D. Listening to patients, for the patients: the COVAD Study-Vision, organizational structure, and challenges [Internet]. International journal of rheumatic diseases. 2024 ; 27( 5):[citado 2025 jun. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76828
Vancouver
Joshi M, Darooka N, Saha S, Dyball S, Sen P, Yaadav P, Javaid M, Kadam E, Shinjo SK, Dey D. Listening to patients, for the patients: the COVAD Study-Vision, organizational structure, and challenges [Internet]. International journal of rheumatic diseases. 2024 ; 27( 5):[citado 2025 jun. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76828
Artigo de periodico
Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD study (2024)
Sandhu, Nimrat Kaur; Ravichandran, Naveen ; Nune, Arvind; Day, Jessica ; Sen, Parikshit ; Nikiphorou, Elena ; Tan, Ai Lyn; Joshi, Mrudula; Saha, Sreoshy ; Shinjo, Samuel Katsuyuki
Fonte: INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES. Unidade: FM
Assuntos: COVID-19, DOENÇAS AUTOIMUNES, DOENÇAS REUMÁTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANDHU, Nimrat Kaur et al. Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD study. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, v. 27, n. 1, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57853. Acesso em: 27 jun. 2025.
APA
Sandhu, N. K., Ravichandran, N., Nune, A., Day, J., Sen, P., Nikiphorou, E., et al. (2024). Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD study. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 27( 1). doi:10.1111/1756-185X.14961
NLM
Sandhu NK, Ravichandran N, Nune A, Day J, Sen P, Nikiphorou E, Tan AL, Joshi M, Saha S, Shinjo SK. Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD study [Internet]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES. 2024 ; 27( 1):[citado 2025 jun. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57853
Vancouver
Sandhu NK, Ravichandran N, Nune A, Day J, Sen P, Nikiphorou E, Tan AL, Joshi M, Saha S, Shinjo SK. Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD study [Internet]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES. 2024 ; 27( 1):[citado 2025 jun. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57853
Artigo de periodico
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and-2 surveys (2024)
Naveen, R ; Sen, Parikshit ; Griger, Zoltan; Day, Jessica ; Joshi, Mrudula; Nune, Arvind; Nikiphorou, Elena ; Saha, Sreoshy ; Tan, Ai Lyn; Shinjo, Samuel Katsuyuki
Fonte: RHEUMATOLOGY. Unidade: FM
Assuntos: COVID-19, VACINAS, MIOSITE, COMORBIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAVEEN, R et al. Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and-2 surveys. RHEUMATOLOGY, v. 63, n. 1, p. 127-139, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57851. Acesso em: 27 jun. 2025.
APA
Naveen, R., Sen, P., Griger, Z., Day, J., Joshi, M., Nune, A., et al. (2024). Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and-2 surveys. RHEUMATOLOGY, 63( 1), 127-139. doi:10.1093/rheumatology/kead180
NLM
Naveen R, Sen P, Griger Z, Day J, Joshi M, Nune A, Nikiphorou E, Saha S, Tan AL, Shinjo SK. Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and-2 surveys [Internet]. RHEUMATOLOGY. 2024 ; 63( 1): 127-139.[citado 2025 jun. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57851
Vancouver
Naveen R, Sen P, Griger Z, Day J, Joshi M, Nune A, Nikiphorou E, Saha S, Tan AL, Shinjo SK. Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and-2 surveys [Internet]. RHEUMATOLOGY. 2024 ; 63( 1): 127-139.[citado 2025 jun. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57851
Artigo de periodico
Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study (2024)
Chatterjee, Tulika; Ravichandran, Naveen ; Nair, Narmadha; Gracia-Ramos, Abraham Edgar; Barman, Bhupen; Sen, Parikshit ; Joshi, Mrudula; Saha, Sreoshy ; Nune, Arvind; Pande, Arun Kumar R; Shinjo, Samuel Katsuyuki
Fonte: JOURNAL OF DIABETES INVESTIGATION. Unidade: FM
Assuntos: COVID-19, DIABETES MELLITUS INSULINO-DEPENDENTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHATTERJEE, Tulika et al. Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study. JOURNAL OF DIABETES INVESTIGATION, v. 15, n. 1, p. 131-138, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57840. Acesso em: 27 jun. 2025.
APA
Chatterjee, T., Ravichandran, N., Nair, N., Gracia-Ramos, A. E., Barman, B., Sen, P., et al. (2024). Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study. JOURNAL OF DIABETES INVESTIGATION, 15( 1), 131-138. doi:10.1111/jdi.14079
NLM
Chatterjee T, Ravichandran N, Nair N, Gracia-Ramos AE, Barman B, Sen P, Joshi M, Saha S, Nune A, Pande AKR, Shinjo SK. Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study [Internet]. JOURNAL OF DIABETES INVESTIGATION. 2024 ; 15( 1): 131-138.[citado 2025 jun. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57840
Vancouver
Chatterjee T, Ravichandran N, Nair N, Gracia-Ramos AE, Barman B, Sen P, Joshi M, Saha S, Nune A, Pande AKR, Shinjo SK. Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study [Internet]. JOURNAL OF DIABETES INVESTIGATION. 2024 ; 15( 1): 131-138.[citado 2025 jun. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57840
Artigo de periodico
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey (2024)
Ahmed, Sakir; Gupta, Latika; Kuwana, Masataka; Pauling, John D; Day, Jessica; Ravichandran, Naveen; Joshi, Mrudula; Parodis, Ioannis; Sen, Parikshit; Shinjo, Samuel Katsuyuki
Fonte: Rheumatology international. Unidade: FM
Assuntos: DOENÇAS AUTOIMUNES, COVID-19, QUESTIONÁRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AHMED, Sakir et al. Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey. Rheumatology international, v. 44, n. 1, p. 89-97, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/76832. Acesso em: 27 jun. 2025.
APA
Ahmed, S., Gupta, L., Kuwana, M., Pauling, J. D., Day, J., Ravichandran, N., et al. (2024). Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey. Rheumatology international, 44( 1), 89-97. doi:10.1007/s00296-023-05433-z
NLM
Ahmed S, Gupta L, Kuwana M, Pauling JD, Day J, Ravichandran N, Joshi M, Parodis I, Sen P, Shinjo SK. Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey [Internet]. Rheumatology international. 2024 ; 44( 1): 89-97.[citado 2025 jun. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76832
Vancouver
Ahmed S, Gupta L, Kuwana M, Pauling JD, Day J, Ravichandran N, Joshi M, Parodis I, Sen P, Shinjo SK. Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey [Internet]. Rheumatology international. 2024 ; 44( 1): 89-97.[citado 2025 jun. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76832
Artigo de periodico
Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study (2023)
Doskaliuk, Bohdana; Ravichandran, Naveen ; Sen, Parikshit ; Day, Jessica ; Joshi, Mrudula; Nune, Arvind; Nikiphorou, Elena ; Saha, Sreoshy ; Tan, Ai Lyn; Shinjo, Samuel Katsuyuki
Fonte: Rheumatology international. Unidade: FM
Assuntos: VACINAÇÃO, COVID-19, MIOSITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DOSKALIUK, Bohdana et al. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study. Rheumatology international, v. 43, n. 9, p. 1651-1664, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/55968. Acesso em: 27 jun. 2025.
APA
Doskaliuk, B., Ravichandran, N., Sen, P., Day, J., Joshi, M., Nune, A., et al. (2023). Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study. Rheumatology international, 43( 9), 1651-1664. doi:10.1007/s00296-023-05345-y
NLM
Doskaliuk B, Ravichandran N, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, Saha S, Tan AL, Shinjo SK. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study [Internet]. Rheumatology international. 2023 ; 43( 9): 1651-1664.[citado 2025 jun. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55968
Vancouver
Doskaliuk B, Ravichandran N, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, Saha S, Tan AL, Shinjo SK. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study [Internet]. Rheumatology international. 2023 ; 43( 9): 1651-1664.[citado 2025 jun. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55968
Artigo de periodico
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study (2023)
Ali, Sasha Saadia; Naveen, R ; Sen, Parikshit ; Day, Jessica ; Joshi, Mrudula; Nune, Arvind; Nikiphorou, Elena ; Saha, Sreoshy ; Tan, Ai Lyn; Shinjo, Samuel Katsuyuki
Fonte: Rheumatology. Unidade: FM
Assuntos: COVID-19, MIOPATIAS MITOCONDRIAIS, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALI, Sasha Saadia et al. Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study. Rheumatology, v. 62, n. 9, p. E263-E268, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/55993. Acesso em: 27 jun. 2025.
APA
Ali, S. S., Naveen, R., Sen, P., Day, J., Joshi, M., Nune, A., et al. (2023). Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study. Rheumatology, 62( 9), E263-E268. doi:10.1093/rheumatology/kead149
NLM
Ali SS, Naveen R, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, Saha S, Tan AL, Shinjo SK. Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study [Internet]. Rheumatology. 2023 ; 62( 9): E263-E268.[citado 2025 jun. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55993
Vancouver
Ali SS, Naveen R, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, Saha S, Tan AL, Shinjo SK. Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study [Internet]. Rheumatology. 2023 ; 62( 9): E263-E268.[citado 2025 jun. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55993
Artigo de periodico
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey (2023)
Naveen, R; Thakare, Darpan; Kuwana, Masataka; Pauling, John; Day, Jessica; Joshi, Mrudula; Parodis, Ioannis; Sen, Parikshit; Jagtap, Kshitij; Shinjo, Samuel Katsuyuki
Fonte: RHEUMATOLOGY INTERNATIONAL. Unidade: FM
Assuntos: DOENÇAS AUTOIMUNES, DOENÇAS REUMÁTICAS, VACINAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAVEEN, R et al. Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey. RHEUMATOLOGY INTERNATIONAL, v. 43, n. 7, p. 1265-1275, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57846. Acesso em: 27 jun. 2025.
APA
Naveen, R., Thakare, D., Kuwana, M., Pauling, J., Day, J., Joshi, M., et al. (2023). Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey. RHEUMATOLOGY INTERNATIONAL, 43( 7), 1265-1275. doi:10.1007/s00296-023-05310-9
NLM
Naveen R, Thakare D, Kuwana M, Pauling J, Day J, Joshi M, Parodis I, Sen P, Jagtap K, Shinjo SK. Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey [Internet]. RHEUMATOLOGY INTERNATIONAL. 2023 ; 43( 7): 1265-1275.[citado 2025 jun. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57846
Vancouver
Naveen R, Thakare D, Kuwana M, Pauling J, Day J, Joshi M, Parodis I, Sen P, Jagtap K, Shinjo SK. Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey [Internet]. RHEUMATOLOGY INTERNATIONAL. 2023 ; 43( 7): 1265-1275.[citado 2025 jun. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57846
Artigo de periodico
COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis (2023)
Naveen, R; Parodis, Ioannis; Joshi, Mrudula; Sen, Parikshit; Lindblom, Julius; Agarwal, Vishwesh; Lilleker, James B; Tan, Ai Lyn; Nune, Arvind; Shinjo, Samuel Katsuyuki
Fonte: Rheumatology. Unidade: FM
Assuntos: COVID-19, VACINAS VIRAIS, DOENÇAS AUTOIMUNES, ARTRITE REUMATOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAVEEN, R et al. COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis. Rheumatology, v. 62, n. 7, p. 2366-2376, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54578. Acesso em: 27 jun. 2025.
APA
Naveen, R., Parodis, I., Joshi, M., Sen, P., Lindblom, J., Agarwal, V., et al. (2023). COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis. Rheumatology, 62( 7), 2366-2376. doi:10.1093/rheumatology/keac624
NLM
Naveen R, Parodis I, Joshi M, Sen P, Lindblom J, Agarwal V, Lilleker JB, Tan AL, Nune A, Shinjo SK. COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis [Internet]. Rheumatology. 2023 ; 62( 7): 2366-2376.[citado 2025 jun. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54578
Vancouver
Naveen R, Parodis I, Joshi M, Sen P, Lindblom J, Agarwal V, Lilleker JB, Tan AL, Nune A, Shinjo SK. COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis [Internet]. Rheumatology. 2023 ; 62( 7): 2366-2376.[citado 2025 jun. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54578
Artigo de periodico
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys (2023)
Sen, Parikshit; Naveen, R; Houshmand, Nazanin; Kia, Siamak Moghadam; Joshi, Mrudula; Saha, Sreoshy; Jagtap, Kshitij; Agarwal, Vishwesh; Nune, Arvind; Shinjo, Samuel Katsuyuki
Fonte: Rheumatology. Unidade: FM
Assuntos: DOENÇAS AUTOIMUNES, DOENÇAS REUMÁTICAS, COVID-19, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEN, Parikshit et al. Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys. Rheumatology, v. 62, n. 10, p. 3291-3301, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57343. Acesso em: 27 jun. 2025.
APA
Sen, P., Naveen, R., Houshmand, N., Kia, S. M., Joshi, M., Saha, S., et al. (2023). Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys. Rheumatology, 62( 10), 3291-3301. doi:10.1093/rheumatology/kead057
NLM
Sen P, Naveen R, Houshmand N, Kia SM, Joshi M, Saha S, Jagtap K, Agarwal V, Nune A, Shinjo SK. Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys [Internet]. Rheumatology. 2023 ; 62( 10): 3291-3301.[citado 2025 jun. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57343
Vancouver
Sen P, Naveen R, Houshmand N, Kia SM, Joshi M, Saha S, Jagtap K, Agarwal V, Nune A, Shinjo SK. Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys [Internet]. Rheumatology. 2023 ; 62( 10): 3291-3301.[citado 2025 jun. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57343
Artigo de periodico
COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies (2022)
Gil-Vila, Albert; Ravichandran, Naveen; Selva-O'callaghan, Albert; Sen, Parikshit; Nune, Arvind; Gaur, Prithvi Sanjeevkumar; Gonzalez, Raquel Aranega; Lilleker, James B; Joshi, Mrudula; Shinjo, Samuel Katsuyuki
Fonte: Muscle & nerve. Unidade: FM
Assuntos: COVID-19, DERMATOPATIAS, MIOSITE, REUMATOLOGIA, VACINAÇÃO, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIL-VILA, Albert et al. COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies. Muscle & nerve, v. 66, n. 4, p. 426-437, 2022Tradução . . Disponível em: https://doi.org/10.1002/mus.27681. Acesso em: 27 jun. 2025.
APA
Gil-Vila, A., Ravichandran, N., Selva-O'callaghan, A., Sen, P., Nune, A., Gaur, P. S., et al. (2022). COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies. Muscle & nerve, 66( 4), 426-437. doi:10.1002/mus.27681
NLM
Gil-Vila A, Ravichandran N, Selva-O'callaghan A, Sen P, Nune A, Gaur PS, Gonzalez RA, Lilleker JB, Joshi M, Shinjo SK. COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies [Internet]. Muscle & nerve. 2022 ; 66( 4): 426-437.[citado 2025 jun. 27 ] Available from: https://doi.org/10.1002/mus.27681
Vancouver
Gil-Vila A, Ravichandran N, Selva-O'callaghan A, Sen P, Nune A, Gaur PS, Gonzalez RA, Lilleker JB, Joshi M, Shinjo SK. COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies [Internet]. Muscle & nerve. 2022 ; 66( 4): 426-437.[citado 2025 jun. 27 ] Available from: https://doi.org/10.1002/mus.27681
Artigo de periodico
COVAD survey 2 long-term outcomes: unmet need and protocol (2022)
Fazal, Zoha Zahid; Sen, Parikshit; Joshi, Mrudula; Ravichandran, Naveen; Lilleker, James B; Agarwal, Vishwesh; Kardes, Sinan; Kim, Minchul; Day, Jessica; Shinjo, Samuel Katsuyuki
Fonte: Rheumatology international. Unidade: FM
Assuntos: DOENÇAS AUTOIMUNES, COVID-19, VACINAÇÃO, PANDEMIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAZAL, Zoha Zahid et al. COVAD survey 2 long-term outcomes: unmet need and protocol. Rheumatology international, v. 42, n. 12, p. 2151-2158, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00296-022-05157-6. Acesso em: 27 jun. 2025.
APA
Fazal, Z. Z., Sen, P., Joshi, M., Ravichandran, N., Lilleker, J. B., Agarwal, V., et al. (2022). COVAD survey 2 long-term outcomes: unmet need and protocol. Rheumatology international, 42( 12), 2151-2158. doi:10.1007/s00296-022-05157-6
NLM
Fazal ZZ, Sen P, Joshi M, Ravichandran N, Lilleker JB, Agarwal V, Kardes S, Kim M, Day J, Shinjo SK. COVAD survey 2 long-term outcomes: unmet need and protocol [Internet]. Rheumatology international. 2022 ; 42( 12): 2151-2158.[citado 2025 jun. 27 ] Available from: https://doi.org/10.1007/s00296-022-05157-6
Vancouver
Fazal ZZ, Sen P, Joshi M, Ravichandran N, Lilleker JB, Agarwal V, Kardes S, Kim M, Day J, Shinjo SK. COVAD survey 2 long-term outcomes: unmet need and protocol [Internet]. Rheumatology international. 2022 ; 42( 12): 2151-2158.[citado 2025 jun. 27 ] Available from: https://doi.org/10.1007/s00296-022-05157-6

Unidades USP

ReP

Filtros

Autores

Assuntos

Título da fonte

Agência de fomento

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos